SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

Inozyme Pharma Q1 Net Loss Narrows

05/12/2021 02:29

06:17 AM EDT, 05/12/2021 (MT Newswires) -- Inozyme Pharma (INZY) reported Wednesday a Q1 net loss of $0.47 per diluted share, compared with a loss of $6.42 per share a year ago.

Four analysts polled by Capital IQ expected a loss of $0.54 per share.

The company did not report revenue for the quarter.

Cash, cash equivalents and investments were $147.6 million as of March 31.

Price: 16.15, Change: +0.15, Percent Change: +0.94